Oncology Institute Inc
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as education… Read more
Oncology Institute Inc (TOI) - Total Assets
Latest total assets as of September 2025: $163.62 Million USD
Based on the latest financial reports, Oncology Institute Inc (TOI) holds total assets worth $163.62 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Oncology Institute Inc - Total Assets Trend (2019–2024)
This chart illustrates how Oncology Institute Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Oncology Institute Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Oncology Institute Inc's total assets of $163.62 Million consist of 65.1% current assets and 34.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 28.8% |
| Accounts Receivable | $48.68 Million | 28.2% |
| Inventory | $10.04 Million | 5.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $14.81 Million | 8.6% |
| Goodwill | $7.23 Million | 4.2% |
Asset Composition Trend (2019–2024)
This chart illustrates how Oncology Institute Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Oncology Institute Inc's current assets represent 65.1% of total assets in 2024, an increase from 36.6% in 2019.
- Cash Position: Cash and equivalents constituted 28.8% of total assets in 2024, up from 4.1% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 12.0% of total assets, a decrease from 59.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 28.2% of total assets.
Oncology Institute Inc Competitors by Total Assets
Key competitors of Oncology Institute Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
Cengild Medical Berhad
KLSE:0243
|
Malaysia | RM218.07 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
Oncology Institute Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Oncology Institute Inc generates 2.28x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Oncology Institute Inc is currently not profitable relative to its asset base.
Oncology Institute Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.68 | 2.49 | 1.04 |
| Quick Ratio | 1.39 | 2.27 | 0.89 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $44.51 Million | $ 69.67 Million | $ 1.11 Million |
Oncology Institute Inc - Advanced Valuation Insights
This section examines the relationship between Oncology Institute Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.76 |
| Latest Market Cap to Assets Ratio | 1.61 |
| Asset Growth Rate (YoY) | -17.5% |
| Total Assets | $172.72 Million |
| Market Capitalization | $278.45 Million USD |
Valuation Analysis
Above Book Valuation: The market values Oncology Institute Inc's assets above their book value (1.61 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Oncology Institute Inc's assets decreased by 17.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Oncology Institute Inc (2019–2024)
The table below shows the annual total assets of Oncology Institute Inc from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $172.72 Million | -17.46% |
| 2023-12-31 | $209.24 Million | -20.04% |
| 2022-12-31 | $261.67 Million | +28.62% |
| 2021-12-31 | $203.44 Million | +209.70% |
| 2020-12-31 | $65.69 Million | +10.36% |
| 2019-12-31 | $59.52 Million | -- |